Results for tnf translation from Romanian to English

tnf, inclusiv trudexa.
some cases have had fatal outcome.

asocierea cu inhibitori tnf
combination with tnf antagonists

asocierea cu antagonişti ai tnf
combination with tnf antagonists

administrare în asociere cu inhibitori tnf
combination with tnf-inhibitors

răspuns inadecvat la un inhibitor al tnf
inadequate response to tnf inhibitor

administrarea simultană de antagonişti tnf şi de anakinra
concurrent administration of tnf-antagonists and anakinra

au administrarea simultană de antagonişti tnf şi de anakinra
concurrent administration of tnf-antagonists and anakinra

placebo răspuns inadecvat la medicamentul blocant al tnf studiul iii
to

tratamentul cu un inhibitor tnf a fost întrerupt înainte de randomizare.
the tnf antagonist therapy was discontinued prior to randomisation.

se consideră că tipul solubil de tnfr reglează activitatea biologică a tnf.
soluble tnfrs are thought to regulate tnf biological activity.

prin blocarea tnf, etanerceptul atenuează inflamaţia şi alte simptome ale bolilor.
by blocking tnf, etanercept reduces the inflammation and other symptoms of the diseases.

de asemenea, adalimumab modulează reacţiile biologice induse sau reglate de tnf, inclusiv
adalimumab also modulates biological responses that are induced or regulated by tnf, including changes in the levels of adhesion molecules responsible for leukocyte migration (elam-1, vcam-1, and icam-1 with an ic50 of 1-2 x 10-10 m).

rezulatatele remisiei clinice au rămas relativ constante indiferent de expunerea anterioară la antagoniştii tnf.
clinical remission results remained relatively constant irrespective of previous tnf antagonist exposure.

o formă nouă de medicamente, biologice numite tnf-blocante, este acum disponibil.
a newer form of medication, biologics called tnf-blockers, is now available.

deficitul relativ de tnf provocat de tratamentul anti-tnf poate duce la iniţierea unui proces autoimun.
the relative deficiency of tnf caused by anti-tnf therapy may result in the initiation of an autoimmune process.

4. 4 – „ administrarea concomitentă a inhibitorului de tnf alfa şi a anakinra “).
the combination of remicade and anakinra is not recommended (see section 4.4 - "concurrent administration of tnf-alpha inhibitor and anakinra”).

combinaţia cu agenţi blocanţi tnf există experienţă limitată în folosirea abatacept în combinaţie cu agenţi blocanţi tnf (vezi pct.
combination with tnf blocking agents there is limited experience with use of abatacept in combination with tnf blocking agents (see section 5.1).

grupa farmacoterapeutică: inhibitori ai factorului de necroză tumorală alfa (tnf- α).
tumor necrosis factor alpha (tnf- α) inhibitors.

grupa farmacoterapeutică: imunosupresoare, inhibitori ai factorului de necroză tumorală alfa (tnf-α), codul atc: l04ab01
pharmacotherapeutic group: immunosuppressants, tumor necrosis factor alpha (tnf-α) inhibitors,atc code: l04ab01